On the evening of July 28, the journal Nature published an online research paper titled "Structural Basis of Ketamine Acting on Human NMDA Receptors"
Depression is one of the most common mental illnesses
"Depression is not a mental illness, not a lot of people think that the fragile heart, but inside the patient's brain has changed, damaged brain synapses
Academy of Sciences Zhu Shujia, born in 1984, has been engaged in NMDA receptor research for more than ten years.
"This meticulous and interesting study solves an important and timely problem in the structural biology of NMDA receptors
AcademicianZhang Mingjie , a structural biologist, believes that this breakthrough work has extremely important scientific significance and clinical value, and is expected to lead to a better clinical performance of the drug combination for the treatment of depression
academician The study by the China Ke Xueyuan Innovation Center for Science and Intelligent Technology Excellence (Institute of Neuroscience) State Key Laboratory of Brain, Neuroscience, Brain Science and the Shanghai Brain Research Center Zhu Shujia class research group Zhong Keyuan Shanghai Institute of Materia Medica Luo Research Group The cooperation is complete
Academy of Sciences Zhong ASTRI ASTRI
This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only.
This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of
the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed
description of the concern or complaint, to
service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content
will be removed immediately.
